MedPath

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin

Phase 3
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Drug: HOE901-U300 (new formulation of insulin glargine)
Registration Number
NCT01499082
Lead Sponsor
Sanofi
Brief Summary

Primary Objective:

* To compare the efficacy of insulin glargine new formulation and Lantus in terms of change in HbA1c from baseline to endpoint (scheduled month 6) in adult participants with type 2 diabetes mellitus

Secondary Objectives:

* To compare the efficacy of insulin glargine new formulation and Lantus in terms of occurrence of nocturnal Hypoglycemia

Detailed Description

The maximum study duration was up to approximately 58 weeks per participant, consisting of:

* up to 2 week screening period

* 6-month comparative efficacy and safety treatment period

* 6-month comparative safety extension period

* 4-week safety follow-up period in a subset of participants

* a 3-month administration substudy period starting after completion of the 6-month study period for participants willing to in a subset of participants randomized to HOE901-U300

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
807
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
HOE901-U300HOE901-U300 (new formulation of insulin glargine)-
LantusLantus (insulin glargine)-
Primary Outcome Measures
NameTimeMethod
Change in HbA1c From Baseline to Month 6 EndpointBaseline, Month 6
Secondary Outcome Measures
NameTimeMethod
Percentage of Participants With At Least One Severe and/or Confirmed Nocturnal Hypoglycemia From Start of Week 9 to Month 6 EndpointWeek 9 Up to Month 6

Nocturnal hypoglycemia was hypoglycemia that occurred between 00:00 and 05:59 hours (clock time), regardless the participant was awake or woke up because of the event. Severe hypoglycemia was an event that required assistance of another person to actively administer carbohydrate, glucagon, or other resuscitative actions. Confirmed hypoglycemia was an event associated with plasma glucose less than or equal to (\<=) 3.9 millimoles per liter (mmol/L) (70 milligram per deciliter \[mg/dL\]).

Change in Average Preinjection Self-Monitored Plasma Glucose (SMPG) From Baseline to Month 6 EndpointBaseline, Month 6

Pre-injection SMPG was measured within 30 minutes prior to the injection of the study drug. Average was assessed by the mean of at least 3 SMPG calculated over the 7 days preceding the assessment visit.

Change in Variability of Preinjection SMPG From Baseline to Month 6 EndpointBaseline, Month 6

Pre-injection SMPG was measured within 30 minutes prior to the injection of the study drug. Variability was assessed by the mean of coefficient of variation calculated as 100 multiplied by (standard deviation/mean) over at least 3 SMPG measured during the 7 days preceding the assessment visit.

Percentage of Participants With HbA1c <7% at Month 6 EndpointMonth 6
Change in Fasting Plasma Glucose (FPG) From Baseline to Month 6 EndpointBaseline, Month 6
Percentage of Participants With FPG <5.6 mmol/L (<100 mg/dL) at Month 6 EndpointMonth 6
Change in 8-Point SMPG Profiles Per Time Point From Baseline to Month 6 EndpointBaseline, Month 6

Change in each time-point of 8-point SMPG profile: 03:00 hours (clock time) at night; before and 2 hours after breakfast; before and 2 hours after lunch; before and 2 hours after dinner; and at bedtime.

Change in Daily Basal Insulin Dose From Baseline to Month 6 EndpointBaseline, Month 6
Change in Treatment Satisfaction Score Using The Diabetes Treatment Satisfaction Questionnaire (DTSQs) From Baseline to Month 6 EndpointBaseline, Month 6

DTSQ is a validated measure to assess how satisfied participants with diabetes are with their treatment and how they perceive hyper- and hypoglycemia. It consists of 8 questions which are answered on a Likert scale from 0 to 6. DTSQ treatment satisfaction score is the sum of question 1 and 4-8 scores and ranges between 0 and 36, where higher scores indicate more treatment satisfaction.

Percentage of Participants With Hypoglycemia (All and Nocturnal) Events From Baseline up to Month 12Up to Month 12

Hypoglycemia events were Severe hypoglycemia (an event that required assistance of another person to actively administer carbohydrate, glucagon, or other resuscitative actions); Documented symptomatic hypoglycemia (typical symptoms of hypoglycemia with plasma glucose level of \<=3.9 mmol/L \[70 mg/dL\]); Asymptomatic hypoglycemia (no typical symptoms of hypoglycemia but plasma glucose level \<=3.9 mmol/L); Probable symptomatic hypoglycemia (an event during which symptoms of hypoglycemia were not accompanied by a plasma glucose determination, but was presumably caused by a plasma glucose level \<=3.9 mmol/L, symptoms treated with oral carbohydrate without a test of plasma glucose); Relative hypoglycemia (an event during which the person with diabetes reported any of the typical symptoms of hypoglycemia, and interpreted the symptoms as indicative of hypoglycemia, but plasma glucose level \>3.9 mmol/L); Severe and/or confirmed a hypoglycemia (plasma glucose \<=3.9 mmol/L).

Trial Locations

Locations (193)

Investigational Site Number 840036

🇺🇸

Baltimore, Maryland, United States

Investigational Site Number 840001

🇺🇸

Dallas, Texas, United States

Investigational Site Number 840155

🇺🇸

Baltimore, Maryland, United States

Investigational Site Number 840082

🇺🇸

Houston, Texas, United States

Investigational Site Number 528006

🇳🇱

Utrecht, Netherlands

Investigational Site Number 528002

🇳🇱

Venlo, Netherlands

Investigational Site Number 840085

🇺🇸

Minneapolis, Minnesota, United States

Investigational Site Number 840058

🇺🇸

Las Vegas, Nevada, United States

Investigational Site Number 840008

🇺🇸

Cincinnati, Ohio, United States

Investigational Site Number 840079

🇺🇸

Greer, South Carolina, United States

Investigational Site Number 840066

🇺🇸

Dearborn, Michigan, United States

Investigational Site Number 840042

🇺🇸

Paducah, Kentucky, United States

Investigational Site Number 840126

🇺🇸

Kalamazoo, Michigan, United States

Investigational Site Number 840143

🇺🇸

Chaska, Minnesota, United States

Investigational Site Number 840043

🇺🇸

Brick, New Jersey, United States

Investigational Site Number 840116

🇺🇸

Des Moines, Iowa, United States

Investigational Site Number 840103

🇺🇸

Flint, Michigan, United States

Investigational Site Number 840122

🇺🇸

Mentor, Ohio, United States

Investigational Site Number 840080

🇺🇸

Lexington, Kentucky, United States

Investigational Site Number 840022

🇺🇸

Southfield, Michigan, United States

Investigational Site Number 840112

🇺🇸

Norfolk, Virginia, United States

Investigational Site Number 840100

🇺🇸

Avon, Indiana, United States

Investigational Site Number 840127

🇺🇸

Vincennes, Indiana, United States

Investigational Site Number 840034

🇺🇸

Rockville, Maryland, United States

Investigational Site Number 840152

🇺🇸

Toms River, New Jersey, United States

Investigational Site Number 124015

🇨🇦

Montreal, Canada

Investigational Site Number 233002

🇪🇪

Pärnu, Estonia

Investigational Site Number 203001

🇨🇿

Breclav, Czechia

Investigational Site Number 840074

🇺🇸

Norfolk, Virginia, United States

Investigational Site Number 203003

🇨🇿

Hradec Kralove, Czechia

Investigational Site Number 840039

🇺🇸

Chattanooga, Tennessee, United States

Investigational Site Number 840035

🇺🇸

Chesapeake, Virginia, United States

Investigational Site Number 840145

🇺🇸

Hickory, North Carolina, United States

Investigational Site Number 840159

🇺🇸

Knoxville, Tennessee, United States

Investigational Site Number 124024

🇨🇦

Beamsville, Canada

Investigational Site Number 840060

🇺🇸

Ogden, Utah, United States

Investigational Site Number 840075

🇺🇸

Williamsburg, Virginia, United States

Investigational Site Number 124006

🇨🇦

Laval, Canada

Investigational Site Number 840007

🇺🇸

Uniontown, Pennsylvania, United States

Investigational Site Number 840048

🇺🇸

Rapid City, South Dakota, United States

Investigational Site Number 840120

🇺🇸

Hurst, Texas, United States

Investigational Site Number 840041

🇺🇸

Norfolk, Virginia, United States

Investigational Site Number 233001

🇪🇪

Tallinn, Estonia

Investigational Site Number 203008

🇨🇿

Praha 2, Czechia

Investigational Site Number 233003

🇪🇪

Tallinn, Estonia

Investigational Site Number 203005

🇨🇿

Prostejov, Czechia

Investigational Site Number 203007

🇨🇿

Hranice, Czechia

Investigational Site Number 233006

🇪🇪

Tallinn, Estonia

Investigational Site Number 348011

🇭🇺

Sátorlaljaújhely, Hungary

Investigational Site Number 528009

🇳🇱

Almelo, Netherlands

Investigational Site Number 528004

🇳🇱

Eindhoven, Netherlands

Investigational Site Number 840003

🇺🇸

Wichita, Kansas, United States

Investigational Site Number 840071

🇺🇸

Phoenix, Arizona, United States

Investigational Site Number 840084

🇺🇸

Portland, Oregon, United States

Investigational Site Number 124023

🇨🇦

Calgary, Canada

Investigational Site Number 124019

🇨🇦

Chatham, Canada

Investigational Site Number 124025

🇨🇦

Burlington, Canada

Investigational Site Number 124018

🇨🇦

Coquitlam, Canada

Investigational Site Number 124021

🇨🇦

Hamilton, Canada

Investigational Site Number 124004

🇨🇦

Montreal, Canada

Investigational Site Number 124008

🇨🇦

Mississauga, Canada

Investigational Site Number 124009

🇨🇦

London, Canada

Investigational Site Number 124002

🇨🇦

Red Deer, Canada

Investigational Site Number 124007

🇨🇦

Thornhill, Canada

Investigational Site Number 124011

🇨🇦

Toronto, Canada

Investigational Site Number 124017

🇨🇦

Ville St-Laurent, Canada

Investigational Site Number 124022

🇨🇦

Winnipeg, Canada

Investigational Site Number 348010

🇭🇺

Baja, Hungary

Investigational Site Number 348008

🇭🇺

Eger, Hungary

Investigational Site Number 348018

🇭🇺

Gyula, Hungary

Investigational Site Number 428002

🇱🇻

Riga, Latvia

Investigational Site Number 428006

🇱🇻

Jekabpils, Latvia

Investigational Site Number 348002

🇭🇺

Budapest, Hungary

Investigational Site Number 348017

🇭🇺

Budapest, Hungary

Investigational Site Number 233004

🇪🇪

Tallinn, Estonia

Investigational Site Number 233005

🇪🇪

Tartu, Estonia

Investigational Site Number 246001

🇫🇮

Helsinki, Finland

Investigational Site Number 246002

🇫🇮

Oulu, Finland

Investigational Site Number 348014

🇭🇺

Makó, Hungary

Investigational Site Number 484007

🇲🇽

Chihuahua, Mexico

Investigational Site Number 246005

🇫🇮

Kuopio, Finland

Investigational Site Number 348013

🇭🇺

Budapest, Hungary

Investigational Site Number 348009

🇭🇺

Budapest, Hungary

Investigational Site Number 348003

🇭🇺

Szeged, Hungary

Investigational Site Number 484004

🇲🇽

Pachuca, Mexico

Investigational Site Number 642008

🇷🇴

Iasi, Romania

Investigational Site Number 642007

🇷🇴

Timisoara, Romania

Investigational Site Number 642006

🇷🇴

Bucuresti, Romania

Investigational Site Number 642009

🇷🇴

Targu Mures, Romania

Investigational Site Number 840067

🇺🇸

Fargo, North Dakota, United States

Investigational Site Number 840068

🇺🇸

Eagan, Minnesota, United States

Investigational Site Number 840070

🇺🇸

Tempe, Arizona, United States

Investigational Site Number 124020

🇨🇦

Calgary, Canada

Investigational Site Number 840156

🇺🇸

Chandler, Arizona, United States

Investigational Site Number 840102

🇺🇸

Glendale, Arizona, United States

Investigational Site Number 840121

🇺🇸

Sun City, Arizona, United States

Investigational Site Number 840015

🇺🇸

Little Rock, Arkansas, United States

Investigational Site Number 840016

🇺🇸

Hot Springs, Arkansas, United States

Investigational Site Number 840076

🇺🇸

Anaheim, California, United States

Investigational Site Number 840032

🇺🇸

Searcy, Arkansas, United States

Investigational Site Number 840124

🇺🇸

Little Rock, Arkansas, United States

Investigational Site Number 840133

🇺🇸

Encino, California, United States

Investigational Site Number 840057

🇺🇸

Huntington Beach, California, United States

Investigational Site Number 840062

🇺🇸

Greenbrae, California, United States

Investigational Site Number 840059

🇺🇸

La Jolla, California, United States

Investigational Site Number 840107

🇺🇸

Palm Springs, California, United States

Investigational Site Number 840004

🇺🇸

La Mesa, California, United States

Investigational Site Number 840099

🇺🇸

Mission Hills, California, United States

Investigational Site Number 840013

🇺🇸

Tustin, California, United States

Investigational Site Number 840114

🇺🇸

Colorado Springs, Colorado, United States

Investigational Site Number 840002

🇺🇸

Walnut Creek, California, United States

Investigational Site Number 840005

🇺🇸

San Diego, California, United States

Investigational Site Number 840136

🇺🇸

Colorado Springs, Colorado, United States

Investigational Site Number 840092

🇺🇸

Longmont, Colorado, United States

Investigational Site Number 840049

🇺🇸

Daytona Beach, Florida, United States

Investigational Site Number 840009

🇺🇸

Jacksonville, Florida, United States

Investigational Site Number 840086

🇺🇸

Jacksonville, Florida, United States

Investigational Site Number 840050

🇺🇸

Hollywood, Florida, United States

Investigational Site Number 840011

🇺🇸

Jacksonville, Florida, United States

Investigational Site Number 840148

🇺🇸

Palm Harbor, Florida, United States

Investigational Site Number 840012

🇺🇸

Ocoee, Florida, United States

Investigational Site Number 840055

🇺🇸

Lawrenceville, Georgia, United States

Investigational Site Number 840023

🇺🇸

New Port Richey, Florida, United States

Investigational Site Number 840020

🇺🇸

McHenry, Illinois, United States

Investigational Site Number 840019

🇺🇸

Springfield, Illinois, United States

Investigational Site Number 840097

🇺🇸

Avon, Indiana, United States

Investigational Site Number 840078

🇺🇸

Avon, Indiana, United States

Investigational Site Number 840089

🇺🇸

Avon, Indiana, United States

Investigational Site Number 840098

🇺🇸

Avon, Indiana, United States

Investigational Site Number 840106

🇺🇸

Columbus, Ohio, United States

Investigational Site Number 840119

🇺🇸

Maumee, Ohio, United States

Investigational Site Number 840083

🇺🇸

Medford, Oregon, United States

Investigational Site Number 840123

🇺🇸

Dayton, Ohio, United States

Investigational Site Number 840047

🇺🇸

Dallas, Texas, United States

Investigational Site Number 124005

🇨🇦

Oshawa, Canada

Investigational Site Number 124014

🇨🇦

Hamilton, Canada

Investigational Site Number 124001

🇨🇦

Toronto, Canada

Investigational Site Number 124010

🇨🇦

Victoria, Canada

Investigational Site Number 124026

🇨🇦

Quebec, Canada

Investigational Site Number 203006

🇨🇿

Beroun, Czechia

Investigational Site Number 203009

🇨🇿

Holesov, Czechia

Investigational Site Number 203002

🇨🇿

Hodonin, Czechia

Investigational Site Number 203004

🇨🇿

Krnov, Czechia

Investigational Site Number 203010

🇨🇿

Olomouc, Czechia

Investigational Site Number 250004

🇫🇷

La Rochelle Cedex, France

Investigational Site Number 276006

🇩🇪

Heidelberg, Germany

Investigational Site Number 276003

🇩🇪

Schwabenheim, Germany

Investigational Site Number 276002

🇩🇪

Riesa, Germany

Investigational Site Number 250002

🇫🇷

Strasbourg, France

Investigational Site Number 348004

🇭🇺

Balatonfüred, Hungary

Investigational Site Number 348015

🇭🇺

Budapest, Hungary

Investigational Site Number 348005

🇭🇺

Debrecen, Hungary

Investigational Site Number 348012

🇭🇺

Mosonmagyaróvár, Hungary

Investigational Site Number 348007

🇭🇺

Nyiregyháza, Hungary

Investigational Site Number 348006

🇭🇺

Szombathely, Hungary

Investigational Site Number 348001

🇭🇺

Zalaegerszeg, Hungary

Investigational Site Number 428005

🇱🇻

Ogre, Latvia

Investigational Site Number 428001

🇱🇻

Riga, Latvia

Investigational Site Number 428003

🇱🇻

Sigulda, Latvia

Investigational Site Number 428004

🇱🇻

Riga, Latvia

Investigational Site Number 484001

🇲🇽

Cuernavaca, Mexico

Investigational Site Number 484006

🇲🇽

Guadalajara, Mexico

Investigational Site Number 484003

🇲🇽

Monterrey, Mexico

Investigational Site Number 528005

🇳🇱

Hoogeveen, Netherlands

Investigational Site Number 528007

🇳🇱

Groningen, Netherlands

Investigational Site Number 528001

🇳🇱

Hoorn, Netherlands

Investigational Site Number 642001

🇷🇴

Bacau, Romania

Investigational Site Number 528008

🇳🇱

Leeuwarden, Netherlands

Investigational Site Number 642005

🇷🇴

Bucuresti, Romania

Investigational Site Number 642002

🇷🇴

Cluj Napoca, Romania

Investigational Site Number 710003

🇿🇦

Johannesburg, South Africa

Investigational Site Number 642004

🇷🇴

Iasi, Romania

Investigational Site Number 642003

🇷🇴

Oradea, Romania

Investigational Site Number 710005

🇿🇦

Alberton, South Africa

Investigational Site Number 710006

🇿🇦

Lenasia, South Africa

Investigational Site Number 710002

🇿🇦

Observatory, South Africa

Investigational Site Number 710008

🇿🇦

Pretoria, South Africa

Investigational Site Number 710001

🇿🇦

Paarl, South Africa

Investigational Site Number 710004

🇿🇦

Somerset West, South Africa

Investigational Site Number 840090

🇺🇸

Fremont, Nebraska, United States

Investigational Site Number 840045

🇺🇸

Wilmington, North Carolina, United States

Investigational Site Number 840010

🇺🇸

Draper, Utah, United States

Investigational Site Number 840052

🇺🇸

Idaho Falls, Idaho, United States

Investigational Site Number 840053

🇺🇸

Kalispell, Montana, United States

Investigational Site Number 840117

🇺🇸

Nampa, Idaho, United States

Investigational Site Number 840146

🇺🇸

Asheville, North Carolina, United States

Investigational Site Number 840065

🇺🇸

Ann Arbor, Michigan, United States

Investigational Site Number 840091

🇺🇸

Omaha, Nebraska, United States

Investigational Site Number 840018

🇺🇸

Milwaukee, Wisconsin, United States

Investigational Site Number 840021

🇺🇸

Austin, Texas, United States

Investigational Site Number 840129

🇺🇸

Austin, Texas, United States

Investigational Site Number 840081

🇺🇸

Austin, Texas, United States

Investigational Site Number 840104

🇺🇸

Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath